2023
Authors
Fiona E. Lithander, Amber Parry Strong, Andrea Braakhuis, Anna Worthington, Meika Foster, Anna Rolleston, Cheryl Davies, Jane Mullaney, Cecilia Ross, Denise Conroy, Troy L. Merry, Richard Gearry, Mark Weatherall, Jeremy D. Krebs
Abstract
Cardiometabolic diseases are highly prevalent in Aotearoa New Zealand. Dietary intake is a modifiable risk factor for such diseases and certain dietary patterns, specifically the Mediterranean diet (MedDiet), are associated with improved metabolic health.
This study aims to test whether an intervention including a Mediterranean dietary pattern incorporating high quality New Zealand foods (NZMedDiet pattern) and behavior change science can improve the metabolic health of participants and their household/whānau.
This is a multi-center, three-stage trial with two parallel group superiority randomized controlled trials (RCTs), and a longitudinal cohort study embedded within the trial design. The primary outcome measure for each stage is the metabolic syndrome severity score (MetSSS). The total recruitment target is 200 index participants and their household/whānau members who participate with them, and the primary analyses will be intention to treat on index participants.
The trial will test whether the NZMedDiet pattern and behavior change support improves the cardiometabolic health of people in Aotearoa New Zealand.
Publication Link
https://www.frontiersin.org/articles/10.3389/fnut.2023.1298743/full